Haemonetics and Twist Bioscience hit 5-year highs
HAE and TWST rose to more than five-year highs, with Haemonetics linked to a renewed deal with CSL Plasma and Twist tied to increased exposure to AI-powered drug discovery.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
3 results loaded. More archive remains to be checked; continue searching.
Stocks rise on triple witching, oil slump and Fed hopes
U.S. stocks are higher in early trade as triple witching approaches, oil falls and investors focus on rate-cut hopes. The piece also cites stronger AI-related money flows, softer housing data and mixed macro prints.
Full Transcript: Kinaxis Q2 2026 Earnings Call
Kinaxis (TSX: KXS ) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This content is powered APIs. For comprehensive financial data and transcripts, visit The full earnings call is available at Summary Kinaxis reported a 5.5%